The use of topical anaesthetic for paediatric pulsed dye laser procedures without a general anaesthetic: a feasibility pilot randomised controlled trial.
Study of adjunct Topical Anaesthetic for Paediatric pulsed dye LasEr procedures (STAPLE): a feasibility pilot trial
Queensland Children's Hospital
50 participants
Oct 11, 2023
Interventional
Conditions
Summary
Children can sometimes have pulsed dye laser procedures for birthmarks and scars without a general anesthetic. Instead of having a general anaesthetic, they instead have pain relief (paracetamol/ibuprofen) before their procedure and have access to additional pain relief during the procedure if required. It is unclear if, in this situation, children might benefit from having a numbing cream (topical anaesthetic) applied to their birthmark or scar before the laser. Any medications have their own risks associated with them, so we want to make sure that if we do start routinely using numbing cream in these situations, that it brings enough of a benefit for children that it would outweigh any associated risks with using numbing cream. We would like to do a study that looks at children's pain scores during and after laser procedures, and whether there is a difference in pain scores of children who have had numbing cream compared to children who receive a placebo (non-active) cream. The first step of doing such a study would be to check that it is feasible to do, and acceptable to everyone who might participate. That is what this feasibility pilot study will aim to do.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Children who will be undergoing laser procedures without a general anaesthetic (pulsed dye laser or Nd:YAG laser) at the Queensland Children's Hospital will be recruited for this study. Participants will be randomly allocated to either the active treatment or placebo group. Those in the active treatment group will receive topical Numit 5% (Lidocaine/Lignocaine 2.5% and Prilocaine 2.5%) cream over the area that is to be treated with pulsed dye laser. This will be approximately 30-60 minutes prior to their procedure, when the children arrive at the Queensland Children's Hospital for their laser procedure, and will be done by pre-operative nursing staff. The cream will be wiped off immediately prior to the procedure. Intervention fidelity will be monitored by the study investigators while the topical anaesthetic or placebo is applied using a fidelity checklist.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12623000494639